The earnings deterioration is severe and structural, margin compression is accelerating while the company navigates accounting restatement fallout, material control weaknesses, and an expanding securities class action. The $750M buyback authorization provides optionality but was unused in H1, suggesting management is conserving liquidity. Watch for further margin erosion in H2 2026 and any developments in the securities litigation (motion to dismiss due September 1, 2026). The $750M 2027 Notes maturity in May 2027 is the next major refinancing event.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 30 $165.53entry
- T+1 · 4mo ago −1.19%α −1.89% · $163.57
- T+5 · 3mo ago −2.63%α −6.26% · $161.17
- T+20 · 3mo ago +2.53%α −1.43% · $169.72
- T+60 · 25d ago +11.93%α +9.46% · $185.27
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
ICON plc reported Q2 2026 results with revenue essentially flat (+1.2% to $2.06B) but net income collapsed 64% to $72.6M from $203.5M a year ago, driven by direct cost margin expansion (76.8% vs 71.4% of revenue), a $32.9M loss on the Symphony disposal, and $20.9M in restructuring charges. Operating income fell 40% to $137.8M. The filing follows the May 2026 20-F that restated FY2023/2024 financials due to improper revenue recognition and disclosed material internal control weaknesses, with an ongoing securities class action now expanded to include additional defendants and claims.
Key Facts
- Q2 2026 revenue $2.06B vs $2.04B (+1.2%); net income $72.6M vs $203.5M (-64.3%)
- Diluted EPS $0.94 vs $2.56 (-63.3%); H1 2026 diluted EPS $2.29 vs $4.54 (-49.6%)
- Operating margin fell to 6.7% from 11.3% as direct costs rose to 76.8% of revenue from 71.4%
- Recorded $32.9M pre-tax loss on disposal of Symphony Health Solutions (May 8, 2026)
- Restructuring charges of $20.9M in Q2 ($31.0M YTD) for workforce reduction
- Securities class action expanded: Second Amended Complaint filed June 26, 2026 adds new plaintiffs, current CFO, and a scheme liability claim under Section 10(b)
- Backlog (unsatisfied performance obligations) grew to $15.7B from $14.9B at year-end 2025
- Cash from operations improved to $448.3M from $414.4M; cash balance $928.4M
- Drew down $500M Bridge Secured Credit Facility on July 15, 2026 to repay maturing 2.875% Senior Secured Notes
- No share repurchases in H1 2026; $750M authorization remains unused
Financial Impact
Net income declined $130.9M YoY in Q2 2026; operating income fell $93.1M; direct cost ratio expanded 540bps to 76.8% of revenue
Risk Factors
- Securities class action could result in material settlement or judgment; Second Amended Complaint expands scope
- Direct cost margin expansion (76.8% vs 71.4%) signals pricing pressure and/or cost overruns that may persist
- Material weaknesses in internal controls over financial reporting remain unresolved, increasing restatement risk
- $750M 2027 Notes mature May 2027, refinancing risk if credit profile continues to weaken
- Ongoing restructuring suggests demand or operational challenges requiring headcount reduction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-050844 |
| Document: icon-ex171guarantorschedul.htm | 0001628280-26-050844 |
| Document: 0001628280-26-050844-index-headers.html | 0001628280-26-050844 |
| Document: 0001628280-26-050844-index.html | 0001628280-26-050844 |
| Document: 0001628280-26-050844.txt | 0001628280-26-050844 |
Track record
25 reports on ICLR
3 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +33.70% at T+60 after the Aug 6, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $190.43 Now $191.40 +0.51% settles Nov 17
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $194.65 to $191.40 Now $191.40 −1.67% ▼ −1.67% +0.24% vs SPY
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $204.63 to $199.70 Now $191.40 −6.47% ▼ −2.41% −3.73% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $201.65 to $204.74 Now $191.40 −5.08% ▲ +1.53% +1.22% vs SPY
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $203.11 to $201.65 Now $191.40 −5.77% ▼ −0.72% +3.69% vs SPY
- Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $203.11 to $201.65 Now $191.40 −5.77% ▼ −0.72% +3.69% vs SPY
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $203.77 to $203.11 Now $191.40 −6.07% ▼ −0.32% −1.98% vs SPY
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $203.77 to $203.11 Now $191.40 −6.07% ▼ −0.32% −1.98% vs SPY
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $203.77 to $203.11 Now $191.40 −6.07% ▼ −0.32% −1.98% vs SPY
- Oct 27, 202620d ago 6-K Bearish 5/10 Entry $214.16 to $215.48 Now $191.40 +10.63% ▼ −0.62% −1.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers